info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Optic Nerve Glioma Market is Projected to Witness Slower Growth at a CAGR Of 6.5 % Over The Forecast Period 2022-2030

Pune, India, August 28, 2022/MRFR Press Release/- Market Research Future has a half cooked research report on the global optic nerve glioma market.


Market Highlights


The Optic Nerve Glioma Market is expected to reach USD 619.7 Million by 2030 at 6.5% CAGR during the forecast period 2022-2030

Optic nerve glioma or optic glioma or juvenile pilocytic astrocytoma is a type of brain tumour primarily affecting the optic nerve cells. Optic nerve gliomas are slow growing, rare and mostly found in children. Its occurrence in individuals over age 20 is quite rare and any other occurrence is associated with the genetic disorder neurofibromatosis type 1, or NF1 in approximately 30% of the cases. Symptoms of an optic nerve glioma are nausea and vision disturbances, vomiting, balance problems, involuntary eye movements, memory impairment, delay in growth etc. daytime sleepiness is also witnessed in a large number of patients. The pressure exerted by these tumours may cause secondary effects such as hormonal problems due to effects on the pituitary gland. Optic nerve gliomas comprise about 1% of all intracranial tumours. About 10% of optic nerve gliomas are located within an optic nerve, one third in both optic nerve and chiasm which is an area where the left and right optic nerves cross and approximately one third involve the chiasm itself. The remaining one fourth optic nerve gliomas are in the hypothalamus and approximately 5 .5% gliomas are multi-centric.


Product development and development of novel drugs is the most attractive strategy for the optic nerve glioma industry. As there is no effective treatment for malignant optic nerve gliomas, advent of any novel drug will have a remarkable effect on the existing treatment market. Any novel drug is expected to be a market leader with minimum marketing expenditure. The high development cost of novel anticancer drugs is a constraint on the market. Thus, pioneering in the drug development can pose to benefit the new entrants of the market.


Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Optic Nerve Glioma Market Research Report


Global Optic Nerve Glioma Market Players


Key players profiled in the report are Emcure pharmaceuticals ltd., Sigma-Aldrich Co., ThermoFisher Scientific Inc., Pfizer Inc., Taj Pharmaceuticals Limited, Novartis International AG, Teva Pharmaceutical Industries Ltd, GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation and others and others.


Regional Analysis


The global optic nerve glioma market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.


The Americas dominate this market, particularly North America due to high healthcare expenditure in the region.


Rising screening are major drivers for the growth of Europe optic nerve glioma market. Some other factors such as growing cancer research, advanced healthcare facilities, and adoption of new therapies are driving the growth for the market.


Asia Pacific is the fastest growing and high potential market for optic nerve glioma. This growth is majorly attributed to developing healthcare sector, changing healthcare practices, growing number of cases and rising demand from the countries like China..


The Middle East & Africa region is expected to have limited growth due to some factors such as traditional healthcare practices, limited access and availability of the products, poor public healthcare expenditure etc.


Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Optic Nerve Glioma Market” Research Report – Forecast till 2030.


Segmentation


The global optic nerve glioma market has been segmented on the basis of types, diagnosis, treatment and end users.


Based on types, the market has been segmented as malignant optic nerve glioma and benign optic nerve glioma.


Based on the diagnosis, the market has been segmented into neurological exam, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), biopsy and others.


Based on the treatment, the market has been segmented into surgery, radiation therapy, chemotherapy and others.


Based on the end users, the market has been segmented as hospitals and clinics, diagnostic centers and others.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Companies Covered 15
Pages 90
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.